Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Vistagen Therapeutics.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Vistagen Therapeutics.

Recommendation Trends

Rating	Jul '23	Aug '23	Sep '23	Oct '23	Nov '23	Dec '23
Strong Buy	0	1	1	1	2	0
Buy	0	0	0	0	0	0
Hold	2	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	1	1	1	2	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Tsai Jefferies	Jefferies	Hold → Strong Buy Upgrades $0.2 → $15	Hold → Strong Buy	Upgrades	$0.2 → $15	+527.62%	Dec 7, 2023
Paul Matteis Stifel	Stifel	Strong Buy Initiates $12	Strong Buy	Initiates	$12	+402.09%	Nov 14, 2023
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+1,155.23%	Sep 5, 2023
Jason McCarthy Maxim Group	Maxim Group	Hold → Strong Buy Upgrades $30	Hold → Strong Buy	Upgrades	$30	+1,155.23%	Aug 7, 2023
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 26, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

724.54K

Decreased by -31.90%

from 1.06M

Revenue Next Year

438.60K

Decreased by -39.46%

from 724.54K

EPS This Year

-1.77

from -1.52

EPS Next Year

-1.71

from -1.77

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	-	1.09M	1.11M	-227.00K	1.06M	724.54K	438.60K	4.58M
Revenue Growth	-	-	1.78%	-	-	-31.90%	-39.46%	943.32%
EPS	-15.07	-14.74	-7.38	-8.51	-1.52	-1.77	-1.71	-1.90
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.2M	1.4M	8.9M
Avg	724,537	438,600	4.6M
Low	490,000	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	11.6%	87.0%	1,925.3%
Avg	-31.9%	-39.5%	943.3%
Low	-53.9%	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-1.79	-1.35	-1.52
Avg	-1.77	-1.71	-1.90
Low	-1.73	-2.29	-2.17

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.